Skip to content
  • Science
    • ENT-03
    • ENT-21
    • ENT-AD
  • Pipeline
    • Pipeline
  • People
    • Advisors
    • Board of Directors
    • Leadership
  • News
  • Publications
  • Contact
NewsCorey Thomasson2025-08-21T19:36:15+00:00

Press Releases & News

Explore our latest press releases and news here.  Discover our advancements in weight loss drug development and other related fields. Stay updated on our cutting-edge studies and insights, all in one place.

  • June 27, 2025 – Metabolics Pharma Announces ENT-03 Generates Sustained Weight Loss and Liver Pathology Improvements in an Animal Model for Obesity
  • June 25, 2025 – Metabolics Pharma Announces Positive Top-Line Results from Phase 1a Clinical Trial of ENT-03 in Obese and Diabetic Subjects
  • June 24, 2023 – Enterin Presents Data Demonstrating Strong Benefit of ENT-03 on Body Weight, Adiposity and Blood Glucose Vs. Semaglutide in a Diet Induced Obesity Mouse Model
  • June 5, 2023 – Enterin Announces the Start of a First-in-Human Study of ENT-03 in Obesity and Type 2 Diabetes
  • February 1, 2023 – Enterin Announces ENT-03 Benefit in MASH

Metabolics Pharma, INC

© 2026 · All Rights Reserved · Privacy Policy

Page load link
Go to Top